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Background: The lung is exposed to airborne fungal spores, and fungi that colonize the oral cavity such as
Candida albicans, but does not develop disease to opportunistic fungal pathogens unless the immune system is
compromised. The Group IVA cytosolic phospholipase A2 (cPLA2α) is activated in response to Candida albicans
infection resulting in the release of arachidonic acid for eicosanoid production. Although eicosanoids such as
prostaglandins and leukotrienes modulate inflammation and immune responses, the role of cPLA2α and
eicosanoids in regulating C. albicans lung infection is not understood.
Methods: The responses of cPLA2α+/+ and cPLA2α−/− Balb/c mice to intratracheal instillation of C. albicans were
compared. After challenge, we evaluated weight loss, organ fungal burden, and the recruitment of cells and the
levels of cytokines and eicosanoids in bronchoalveolar lavage fluid. The ability of macrophages and neutrophils
from cPLA2α+/+ and cPLA2α−/− mice to recognize and kill C. albicans was also compared.
Results: After C. albicans instillation, cPLA2α+/+ mice recovered a modest weight loss by 48 h and completely
cleared fungi from the lung by 12 h with no dissemination to the kidneys. In cPLA2α−/− mice, weight loss
continued for 72 h, C. albicans was not completely cleared from the lung and disseminated to the kidneys.
cPLA2α−/− mice exhibited greater signs of inflammation including higher neutrophil influx, and elevated levels of
albumin and pro-inflammatory cytokines/chemokines (IL1α, IL1β, TNFα, IL6, CSF2, CXCL1, CCL20) in bronchoalveolar
lavage fluid. The amounts of cysteinyl leukotrienes, thromboxane B2 and prostaglandin E2 were significantly lower
in bronchoalveolar lavage fluid from C. albicans-infected cPLA2α−/− mice compared to cPLA2α+/+ mice. Alveolar
macrophages and neutrophils from uninfected cPLA2α−/− mice exhibited less killing of C. albicans in vitro than cells
from cPLA2α+/+ mice. In addition alveolar macrophages from cPLA2α−/− mice isolated 6 h after instillation of GFP-C.
albicans contained fewer internalized fungi than cPLA2α+/+ macrophages.
Conclusions: The results demonstrate that cPLA2α contributes to immune surveillance and host defense in the
lung to prevent infection by the commensal fungus C. albicans and to dampen inflammation.
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Group IVA cytosolic phospholipase A2 (cPLA2α) re-
leases arachidonic acid to initiate eicosanoid production
[1]. Eicosanoids are secreted and act locally through G-
protein coupled receptors, which are expressed in a
cell-type specific manner and initiate distinct signaling
pathways to promote diverse biological responses [2–4].
Arachidonic acid is metabolized by 5-lipoxygenase (5-
LO) to leukotrienes, and by constitutive cyclooxygenase
(COX)-1 and inducible COX-2 to prostaglandins and
thromboxane [5, 6]. Leukotrienes are pro-inflammatory
mediators produced by macrophages, dendritic cells,
mast cells, basophils and eosinophils that regulate cell
trafficking, cytokine production, vascular permeability
and phagocyte function [7]. The cysteinyl leukotrienes
including leukotriene C4, leukotriene D4 and leukotri-
ene E4 are bronchoconstrictors involved in asthma and
allergic responses [2]. cPLA2α and COXs are widely
expressed reflecting the ability of most cells and tissues
to produce prostanoids, which have diverse functions
[1, 6]. Prostaglandins regulate normal physiological
processes such as female reproduction, hemostasis, kid-
ney function and the maintenance of the gastrointes-
tinal tract [1]. Although prostaglandins promote acute
and chronic inflammation in response to tissue injury
they also play a role in the resolution of inflammation
and can be anti-inflammatory and immunosuppressive
[8–10]. Therefore cPLA2α mediates the release of ara-
chidonic acid for the production of numerous bioactive
lipid mediators that have diverse effects [1]. This makes
its role in regulating responses to infection difficult to
predict and would be influenced by the specific tissue
involved and nature of the microorganism.
Eicosanoids are produced rapidly in response to en-
gagement of pattern recognition receptors by microbial
pathogens and modulate immune cell function by af-
fecting phagocytosis, microbial killing, chemotaxis and
the transcriptional program [7, 10, 11]. We have used
resident tissue macrophages from the peritoneal cavity
and the lung to study the mechanisms of cPLA2α
activation by the fungal pathogen Candida albicans
[12–16]. Resident tissue macrophages are sentinel cells
that are first responders to microbial invasion for
initiating host defense to infection [17]. In resident
peritoneal macrophages, activation of cPLA2α by C.
albicans involves engagement of fungal cell wall poly-
saccharides β-glucan and mannans to C-type lectin re-
ceptors dectin-1 and dectin-2, respectively [13, 14].
These receptors act with MyD88-dependent pathways
to activate cPLA2α, which involves calcium-induced
translocation to membrane and phosphorylation by
mitogen-activated protein kinases. In peritoneal mac-
rophages, C. albicans stimulates an autocrine loop in-
volving cPLA2α activation, production of prostaglandinsand increases in cAMP that affects expression of genes
involved in host defense and to dampen inflammation
[15, 16]. In contrast, alveolar macrophages exhibit
distinct properties since C. albicans poorly stimulates
cPLA2α-mediated arachidonic acid release, however,
priming with granulocyte macrophage colony-stimulating
factor (GM-CSF) enhances arachidonic acid release by in-
creasing expression of dectin-1 [12].
The lung has several mechanisms to clear environ-
mental triggers that are continuously inhaled to prevent
excess inflammation and tissue injury that may com-
promise gas exchange function [18]. Candida is the pre-
dominant fungal genus in the oral cavity, and dispersal
of microoganisms from this site to the lung is a mechan-
ism for shaping the lung microbiome [19, 20]. Despite po-
tential exposure from the oral cavity, levels of C. albicans
in the healthy lung are low indicating mechanisms for
efficient clearance to prevent colonization [21, 22]. C.
albicans is a commensal of mucosal surfaces that does not
cause infection unless the immune system is compro-
mised [23, 24]. Candida lung infection occurs in the critic-
ally ill, in patients with cancer and cystic fibrosis, during
organ transplantation and in immune compromised indi-
viduals [21, 25, 26]. By comparing cPLA2α
+/+ and
cPLA2α
−/− mice, we found that cPLA2α contributes to
innate immune defenses in the lung for protection against
C. albicans infection.Methods
Materials
Hank’s Balanced Salts Solution was from Invitrogen
(Carlsbad, CA). ELISA kits were from eBioscience (San
Diego, CA) (IL1α, IL1β, TNFα, IL6), from Immunology
Consultants Laboratory Inc. (Portland, OR) (albumin),
from R&D Systems (Minneapolis, MN) (CCL20) and
from PeproTech (Rocky Hill, NJ) (CXCL1, CSF2,
CSF3). Antibodies for flow cytometry analysis were
from eBioscience (San Diego, CA) (anti-mouse CD45
eF450, CD11c PE, CD24 FITC, CD11b APC, MHC-II
I-A/E PerCP-eF710, CD103 FITC) and from BD Biosci-
ences (San Jose, CA) (anti-mouse Siglec F-PE and
Ly6G (clone 1A8)-PE). QuickIII staining kit for cytos-
pins was obtained from Astral Diagnostics, NJ. Butyl-
ated hydroxytoluene and indomethacin were from
Fisher Scientific. Percoll, collagenase XI, Trypsin in-
hibitor, DNase I, RBC lysis solution were from Sigma-
Aldrich (St. Louis, MO). Nylon cell strainers (70 μm)
were from BD Biosciences (San Jose, CA). Qiasol lysis
reagent, RNeasy Mini Kits and Mouse Cytokines &
Chemokines RT2 Profiler PCR Array were from Qiagen
(Valencia, CA). Paraformaldehyde was from Electron
Microscopy Sciences (Hatfield, PA). XTT Cell Viability
Kit was from Cell signaling.
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cPLA2α
−/− mice were generated as previously described
[27], and backcrossed onto a Balb/c background for 10
generations. Balb/c control mice (cPLA2α
+/+) were ob-
tained from Charles River (San Diego, CA). Mice were
housed under specific pathogen free conditions and
used between 8–14 weeks of age. Male mice were used
for all experiments with exception as noted in the
figure legend. The work with mice was approved by the
Institutional Animal Care and Use Committee (IACUC)
at National Jewish Health and conducted in accordance
with their guidelines.C. albicans challenge
C. albicans (ATCC SC5314) was grown in YPD medium
overnight (30 °C), washed, suspended in endotoxin-free
PBS then counted. Counts correlated directly with colony
forming units (CFU). C. albicans was administered by
intratracheal instillation to cPLA2α
+/+ and cPLA2α
−/−
Balb/c mice under isoflurane anesthesia. The trachea was
intubated with a gavage needle to instill (50 μl) C. albicans
(106–107 CFU) or endotoxin-free PBS. Mice were eutha-
nized by CO2 asphyxiation or cervical dislocation with
similar results. C. albicans expressing green fluorescent
protein (GFP) was kindly provided by Dr. Robert Wheeler,
The University of Maine. It was generated from the wild
type SC5314 strain and exhibits similar virulence as the
wild type strain in mice [28].Bronchoalveolar lavage
Lungs were lavaged 5 times as described [12]. For analysis
of eicosanoids in bronchoalveolar lavage fluid (BALF), the
lavage solution also contained 5 μM indomethacin and
50 μM butylated hydroxytoluene. Cells in lavage were
differentiated on cytospins. Albumin, cytokines and che-
mokines were measured in BALF by ELISA.Fungal burden
Blood was drained by cutting the inferior vena cava, and
then lungs and kidneys were removed asceptically,
weighed and homogenized (Omni Tissue Homogenizer,
Omni International) in sterile phenol red-free HBSS.
Homogenates were serially diluted, plated on Sabouraud
dextrose agar plates containing penicillin and strepto-
mycin, and then C. albicans CFU determined after 48 h
incubation at 37 °C.Histology
Lungs were fixed by inflation (1 ml), immersed in forma-
lin (10 %) then dehydrated and embedded in paraffin.
Sections (5 μm) were stained with H & E.Real-time PCR
Lungs from cPLA2α
+/+ and cPLA2α
−/− mice were homog-
enized with an Omni Tissue Homogenizer in Qiasol lysis
reagent and RNA isolated using on-column DNase treat-
ment. RNA concentration and purity were determined by
UV spectrophotometry, and RNA integrity verified using
an Agilent Bioanalyzer 2100. cDNA was synthesized from
RNA (200 ng) using RT2 First Strand Kit (Qiagen). Real-
time PCR was performed using RT2 qPCR Mastermix and
a Mouse Cytokines & Chemokines RT2 Profiler PCR
Array according to the manufacturer's protocol using
the StepOnePlus Real-Time PCR System (Applied
Biosystems). RT2 PCR arrays in a 96-well format were
used containing pre-validated primers tested for effi-
ciency (Qiagen). The RT2 Profiler PCR Array System
included a reverse transcription control preloaded into
the primer buffer of the RT2 First Strand cDNA synthe-
sis kit that measured the relative efficiency of the re-
verse transcription for all the samples. A genomic DNA
control and a positive PCR control were also included
in the system. The RT2 Profiler PCR Array data were
normalized to the housekeeping gene Gusb and the
relative gene expression level (2^(−ΔCt) was calculated
using the formula ΔCt = Ct (gene of interest)- Ct
(housekeeping gene). The data were analyzed on the
PCR array data analysis SA Biosciences web portal
(http://pcrdataanalysis.sabiosciences.com/pcr/
arrayanalysis.php).
Real-time PCR was also performed with cDNA syn-
thesized with random hexamer primers (Fermentas
Maxima First Strand cDNA Synthesis Kit, Thermo Sci-
entific) using TaqMan fast universal PCR master mix.
TaqMan assay probes used were: Clec7a (dectin-1)
(Mm01183349_m1), Clec4n (dectin-2) (Mm00490934_m1)
and Gusb (Mm01197698_g1). The housekeeping gene
Gusb was used for normalization. Threshold cycle values
(CT) were determined and used for ΔΔCT analysis of gene
expression [29].
Lung digestion and flow cytometry analysis
After performing bronchoalveolar lavage, blood was
drained from the lungs by cutting the inferior vena cava.
Lungs were removed, cut into small pieces followed by
digestion with 5 ml collagenase solution (0.5 mg/ml col-
lagenase XI, 0.2 mg/ml trypsin inhibitor, 5 % FBS in
minimum essential medium) for 1 h at 37 °C with occa-
sional mixing. The digested lungs were sheared with an
18-gauge needle, treated with 50 μl of DNase I solution
(5 mg/ml) and then incubated for 10 min at 37 °C. Lung
digests were filtered through 70-μm nylon cell strainers
and the single cell suspension treated with RBC lysis
solution. Cells were counted using a Countess cell coun-
ter (Invitrogen, Carlsbad, CA) excluding dead cells with
trypan blue. Cells were resuspended in flow cytometry
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PBS) at 2 × 106 cells/ml. All the steps were done at 4 °C.
Cells were dispensed (0.5 x 106 cells in 250 μl) in V-
shaped 96 well plates. After centrifugation at 1500 rpm for
5 min, the supernatant was removed and 50 μl of FcBlock
(anti-CD16/CD32, clone 2.4G2, 40 μg/ml in FC buffer,
eBiosciences) was added followed by incubation on ice for
15 min. Cells were then treated with 50 μl of antibody
cocktails, incubated on ice for 30 min followed by addition
of 150 μl FC buffer then washed in FC buffer. Cells were
fixed with 4 % paraformaldehyde in PBS (100 μl/well),
pH 7.4, then transferred to FC tubes in 300 μl FC buffer
and stored in the dark at 4 °C until analysis. Data were
acquired on a Dako Cyan ADP flow cytometer. Com-
pensation and data analyses were performed using
FlowJo software (TreeStar, Ashland, OR). After the ex-
clusion of doublets and debris, immune cells were iden-
tified by CD45 positive staining. A sequential gating
strategy was used to identify cell populations: alveolar
macrophages (CD45+ CD24− CD11b− SiglecF+); tissue
macrophages (CD45+ CD24− CD11b+); neutrophils
(CD45+ CD11b+ Ly6G+) and CD11b+ dendritic cells
(CD11b+ DCs) (CD45+ MHCII+ CD11c+ CD11b+)
(Additional file 1) [30].
Eicosanoid measurements
BALF stored at −80 °C was thawed and mixed with an
equal volume of cold methanol. Just before analysis, the
samples were diluted in water to a final methanol con-
centration of less than 15 % and then extracted using a
solid phase extraction cartridge (Strata Polymeric Re-
verse Phase 60 mg/ml; Phenomenex, Torrance, CA).
The eluate (1 ml of methanol) was dried and reconsti-
tuted in 75 μl of high-performance liquid chromatog-
raphy (HPLC) solvent A (8.3 mM acetic acid buffered
to pH 5.7 with NH4OH) and 25 μl of solvent B (aceto-
nitrile/methanol, 65/35, v/v). An aliquot of each sample
(30 μl) was injected into an HPLC and metabolites sep-
arated on a C18 column (Kinetex EVO C18 100A 50 x
3.0 mm, 5 μm; Phenomenex, Torrance, CA) eluted at a
flow rate of 0.25 ml/min with a linear gradient from
25 % to 75 % solvent B in 13 min then increased to
98 % in 2 min and held for 11 min. The HPLC system
was directly interfaced into the electrospray ionization
source of a triple quadrapole mass spectrometer (Sciex
API 5500; PE-Sciex, Thornhill, ON, Canada). Mass spec-
trometric analyses were performed in the negative ion
mode using multiple reaction monitoring of the specific
transitions: [d4]PGE2 m/z 355→ 275, [d4]PGD2 m/z
355➔237, [d4]TXB2 m/z 373→ 173, [d4]6-keto-PGF1α
m/z 373➔167, [d5]LTC4 m/z 629→ 271, [d5]LTD4 m/z
500➔177, [d5]LTE4 m/z 443➔338, PGE2 m/z 351→ 271,
PGD2 m/z 351➔233, TXB2 m/z 369→ 169, 6-Keto-PGF1α
m/z 369➔ 163, LTC4 m/z 624→ 272, LTD4 m/z495➔177, LTE4 m/z 438➔333. Quantitation was per-
formed using a standard isotope dilution curve as de-
scribed [31].
C. albicans recognition and killing assays
Alveolar macrophages were isolated from untreated
cPLA2α
+/+ and cPLA2α
−/− mice by lavage and cultured
as previously described [12]. Live opsonized and unop-
sonized GFP-C. albicans (moi 2) was used for all assays.
GFP-C. albicans was opsonized by incubating in
DMEM containing 10 % mouse serum for 30 min at
37 °C before incubation with the macrophages. For
evaluating binding and internalization (recognition
assay), alveolar macrophages (1 × 105) were seeded
onto the glass insert of MatTek 35 mm dishes and in-
cubated for 2 h [12]. Cells were washed then incubated
with GFP-C. albicans in phenol red-free DMEM con-
taining penicillin, streptomycin and 0.1 % endotoxin-
free BSA (stimulation media) for 30 min at 37 °C and
5 % CO2. Macrophages were washed, fixed with 4 %
paraformaldehyde for 15 min and then stained with
DAPI. Images were captured on a Marianas 200 spin-
ning disk confocal microscope using Intelligent Imaging
Innovation Inc. (3I) software (Slidebook 6.0) to deter-
mine the number of macrophages containing GFP-C
albicans. For killing assays, alveolar macrophages (in 48
well plates) were incubated for 2 h in stimulation media
with GFP-C. albicans. Wells containing an equivalent
number of GFP-C. albicans (without macrophages) were
included as a positive control for determining 100 % via-
bility. Macrophages were lysed with 1 % Triton X-100 and
GFP-C. albicans viability was measured using the XTT
Cell Viability Kit as described [32].
Bone marrow neutrophils were isolated from untreated
cPLA2α
+/+ and cPLA2α
−/− mice as described previously
and purity (>95 %) determined on cytospins [33]. Neutro-
phils (1 × 105) were plated on polylysine-coated MatTek
35 mm dishes, incubated for 1 h and then incubated with
GFP-C. albicans for 30 min. After fixation the cells were
incubated for 1 h in PBS containing 10 % FBS and then
incubated overnight with anti-Ly6G antibody followed
by treatment with anti-rabbit AF594 secondary antibody
and with DAPI. For killing assays, GFP-C. albicans was
added to neutrophils (5 × 104) in the 96 well plates, centri-
fuged for 5 min at 300 g to synchronize the infection, and
then incubated for 2 h at 37 °C and 5 % CO2. GFP-C.
albicans viability was determined as described above for
macrophages.
Statistics
The data are presented as mean ± SEM and analyzed
using the 2-tailed unpaired t-test or the Mann Whitney
method to determine statistical significance (defined as
p < 0.05).
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The role of cPLA2α in regulating host defense against C.
albicans lung infection was investigated by comparing
responses of cPLA2α
+/+ and cPLA2α
−/− Balb/c mice. The
LD50 from intratracheal challenge with C. albicans in
immune competent mice is approximately 108 CFU [34].
We first determined if concentrations below the LD50
(106 and 107 CFU) induced weight changes (Fig. 1).
There was significant weight loss from both cPLA2α
+/+
and cPLA2α
−/− mice compared to saline controls 24 h
after instillation of 107 Candida that continued for 72 h
(Fig. 1a). Weight loss was significantly greater from
cPLA2α
−/− than cPLA2α
+/+ mice at 48 and 72 h. Chal-
lenging mice with 106 C. albicans resulted in a small but
significant weight loss in cPLA2α
+/+ mice at 12 and 24 h
compared to saline controls followed by recovery of nor-
mal weight by 48–72 h (Fig. 1b). In cPLA2α
−/− mice
challenged with 106 C. albicans, weight loss continued





challenged with an intermediate amount of C. albicans
(5 × 106 CFU) and survival and body weight monitoredFig. 1 Weight loss is greater in cPLA2α−/− than cPLA2α+/+ mice during C. a
and cPLA2α
+/+ (WT, closed symbols) mice was monitored after intratrachea
inoculum of (a) 107 or (b) 106 CA. Body weight is expressed as the % of th
(n = 8–13 mice/group, from 4–6 independent experiments). *P < 0.05 comp
saline; **P < 0.05 compared to cPLA2α+/+ with CA. c Survival of female cPLA
was monitored after intratracheal administration of 5 x 106 CFU C. albicansfor 28 days. All cPLA2α
+/+ mice survived but 50 % of
cPLA2α
−/− mice died by 72 h with no further mortality
for 28 days (Fig. 1c). cPLA2α
−/− mice lost significantly
more weight (16.5 % ± 1.1), which was greatest at day 4,
than cPLA2α
+/+ mice (6.5 % ± 0.4). The surviving
cPLA2α
−/− mice and all cPLA2α
+/+ mice started gaining
weight after day 4 that returned to normal by ~18 days.
Since the results suggest that cPLA2α regulates early host
defense to C. albicans lung infection, we focused on com-
paring early responses of cPLA2α
+/+ and cPLA2α
−/− mice
up to 72 h after C. albicans challenge.
C. albicans is not cleared completely from the lungs of
cPLA2α
−/− mice and disseminates to the kidney
The ability of cPLA2α
+/+ and cPLA2α
−/− mice to clear C.
albicans was compared by measuring fungal CFU in lung
homogenates. It has previously been reported that im-
mune competent mice are resistant to infection and rap-
idly eliminate C. albicans from the lung [34, 35]. Analysis
of lungs 5 min after intratracheal challenge with 106 C.
albicans confirmed that greater than 90 % of the inoculum
delivered to the lung was recovered in homogenates. By
6 h after instillation most (≥98 %) of the C. albicans was
cleared from the lungs of cPLA2α
+/+ and cPLA2α
−/− micelbicans lung infection. Body weight of cPLA2α−/− (KO, open symbols)
l instillation of saline (squares) or C. albicans (CA, circles) using an
e weight determined just prior to instillation of C. albicans or saline
ared to cPLA2α+/+ with saline; #P < 0.05 compared to cPLA2α−/− with
2α−/− (KO, open symbols) and cPLA2α+/+ (WT, closed symbols) mice
(6 mice/group)
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−/− mice
than cPLA2α
+/+ mice (Fig. 2a). cPLA2α
+/+ mice completely
cleared C. albicans from the lung with no viable fungi re-
covered from 12–72 h after instillation, whereas a signifi-
cant fungal burden persisted in cPLA2α
−/− mice during
this time period. Using a higher inoculum (107 CFU), a
low level of C. albicans was recovered in lungs of
cPLA2α
+/+ mice (150 ± 14 CFU/g) at 72 h, and 30-fold
higher levels in cPLA2α
−/− mice (4567 ± 450 CFU/g). We
also determined if C. albicans breached the lung and dis-
seminated to the kidney, which is the primary target organ
in mice and humans in disseminated candidiasis [36, 37].
C. albicans was recovered from the kidneys of cPLA2α
−/−
mice challenged with 106 CFU at 12 h that further in-
creased from 24–72 h (Fig. 2b). Using an inoculum of
107 CFU, the kidneys of cPLA2α
−/− mice contained con-
siderably more C. albicans than the relatively low level in
mice challenged with 106 CFU. In contrast C. albicans
was not detected in kidneys of cPLA2α
+/+ mice challenged
with 106 or 107 C. albicans (Fig. 2b). The results demon-
strate a critical protective role for cPLA2α in the early
stages of Candida clearance and dissemination in vivo.
Based on these results we investigated differences in the
early host defense responses in cPLA2α
+/+ and cPLA2α
+/+
mice using the lower inoculum of 106 C. albicans.
cPLA2α
−/− mice have higher numbers of neutrophils in
BALF and lung tissue than cPLA2α
+/+ mice during C.
albicans infection
To evaluate the extent of inflammation in cPLA2α
+/+
and cPLA2α
−/− mice, the recruitment of cells into BALF
was compared from 6–72 h after intratracheal instilla-
tion of 106 C. albicans or saline (Fig. 3). The number of
total cells recovered in BALF of untreated (0-time) and
saline control mice was significantly higher (~20 %) in
cPLA2α
−/− than cPLA2α
+/+ mice that was due to higher
numbers of alveolar macrophages (Fig. 3a and b). OverFig. 2 C. albicans is not cleared completely from lungs of cPLA2α−/− mice
(closed circles) mice were challenged with either 106 or 107 C. albicans (CA
(a) lung and (b) kidney (n = 3–14 mice/group, from 3–6 independent expe95 % of the cells in BALF of cPLA2α
+/+ and cPLA2α
−/−
control mice were alveolar macrophages. The number of
total cells in BALF increased 6 h after C. albicans chal-
lenge to a slightly greater level in cPLA2α
−/− mice, then
decreased by 12 h to similar levels in cPLA2α
+/+ and
cPLA2α
−/− mice (Fig. 3a). Between 12 and 24 h after C.
albicans instillation the number of total cells in cPLA2α
+/+
mice slightly declined but increased in cPLA2α
−/− mice
due to greater neutrophil influx (Fig. 3a and c). The num-
ber of alveolar macrophages in BALF increased at 6 h after
C. albicans challenge to similar levels in cPLA2α
+/+ and
cPLA2α
−/− mice followed by a sharp decline in both
strains at 12 h that remained low for 72 h (Fig. 3b). The
decrease in the number of alveolar macrophages is remin-
iscent of the macrophage disappearance reaction observed
in response to inflammation in the peritoneal cavity that is
attributed to macrophage activation resulting in increased
adherence or trafficking [17, 38]. Neutrophils significantly
increased in BALF from cPLA2α
−/− but not cPLA2α
+/+
mice 6 h after C. albicans instillation but then increased
to similar levels in both strains at 12 h (Fig. 3c). Neutro-
phil numbers in cPLA2α
+/+ mice peaked at 12 h but con-
tinued to increase in cPLA2α
−/− mice up to 24 h reaching
levels 2.3-fold higher than in cPLA2α
+/+ mice. Neutrophil
numbers in cPLA2α
−/− mice remained >2-fold higher than
the levels in cPLA2α
+/+ mice up to 72 h after infection
(Fig. 3c). It has been demonstrated that neutrophil influx
into the lung during bacterial pneumonia contributes to
alveolar barrier disruption promoting leakage of plasma
protein into the alveolar space [39]. To determine if the
increased neutrophil influx in C. albicans-infected
cPLA2α
−/− mice was accompanied by an increase in pro-
tein leak into the lung, the amount of albumin in BALF
was determined by ELISA (Fig. 3d). Albumin levels in-
creased at 12 h after C. albicans instillation to a similar
extent in cPLA2α
−/− than cPLA2α
+/+ mice. Albumin levels
increased by 24 h and were 1.8-fold higher in cPLA2α
−/−and disseminates to the kidney. cPLA2α−/− (open circles) and cPLA2α+/+
), and CFU were determined at the indicated times in homogenized
riments). *P < 0.05 compared to cPLA2α+/+
Fig. 3 Neutrophils and albumin are higher in BALF of cPLA2α−/− than cPLA2α+/+ mice during C. albicans infection. The number of (a) total cells,
(b) alveolar macrophages and (c) neutrophils were determined in BALF (5 lavages) from cPLA2α−/− (KO, open symbols) and cPLA2α+/+ (WT, closed
symbols) mice instilled with saline (Sal, squares) or 106 C. albicans (CA, circles). d cPLA2α
+/+ (WT) and cPLA2α
−/− (KO) mice were lavaged 12 and
24 h after instillation of 106 C. albicans or saline. Albumin levels were determined in BALF by ELISA. (n = 8-13 mice/group, from 4–6 independent
experiments). *P < 0.05 compared to cPLA2α+/+ saline control; ϕP < 0.05 compared to cPLA2α+/+ saline control, #P < 0.05 compared to cPLA2α−/−
saline control; **P < 0.05 compared to cPLA2α+/+ with CA
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+/+ mice. The results indicate a
greater compromise of alveolar barrier function in
cPLA2α
−/− mice that correlated with a higher level of
neutrophil influx in response to C. albicans infection.
Cell influx into lung tissue of cPLA2α
+/+ and cPLA2α
−/−
mice 24 h after C. albicans infection was also evaluated by
flow cytometry (Fig. 4). C. albicans infection stimulated a
significant increase in neutrophils (CD45+CD11b+Ly6G+)
in lung tissue of both cPLA2α
+/+ and cPLA2α
−/− mice but
numbers were 2.5-fold higher in cPLA2α
−/− mice (Fig. 4a).
There were similar numbers of alveolar macrophages
(CD45+CD24−CD11b−SiglecF+) in lungs of cPLA2α
+/+ and
cPLA2α
−/− mice, and numbers were not affected by C.
albicans infection (Fig. 4b). This suggests that the higher
number of alveolar macrophages in BALF of uninfected
cPLA2α
−/− mice (see Fig. 3a) may be due to differences in
adherence properties that influence their recovery by lav-
age. C. albicans infection stimulated an increase in tissue
macrophages (CD45+CD24−CD11b+), which were signifi-
cantly higher in cPLA2α
−/− compared to cPLA2α
+/+ mice
(Fig. 4c). The tissue macrophage population, whichincludes both interstitial macrophages and monocytes,
may increase due to recruitment of monocytes from the
blood in response to C. albicans infection. CD11b+ den-
dritic cells (CD45+MHCII+CD11c+CD11b+) increased in
response to C. albicans infection to a greater extent in
cPLA2α
−/− compared to cPLA2α
+/+ mice (Fig. 4d). Repre-
sentative histograms of the flow cytometry analysis are
shown in Additional file 1. Histological examination of
lung sections 24 h after C. albicans challenge showed little
evidence of inflammation other than an occasional small
patch of focal inflammation in cPLA2α
+/+ mice. The
patches of inflammation were markedly larger and more
extensive in cPLA2α
−/− than in cPLA2α
+/+ mice (Fig. 4e).
cPLA2α influences gene expression and cytokine
production in lungs of C. albicans infected mice
We previously reported that activation of cPLA2α in C.
albicans-infected macrophages influences gene expres-
sion through an autocrine loop involving the production
of prostaglandins and increases in cAMP [15, 16]. We
first screened differences in gene expression in total lung
Fig. 4 Effect of C. albicans infection on cell composition and histopathology of lung tissue from cPLA2α+/+ and cPLA2α−/− mice. cPLA2α−/− (KO)
and cPLA2α+/+ (WT) mice were challenged with saline or 106 CFU C. albicans (CA) for 24 h and then lavaged. Lung tissue was processed for
identification of (a) Neutrophils, (b) alveolar macrophages (AM), (c) tissue macrophages (TM) and (d) CD11b+ dendritic cells (DC) by flow
cytometry (n = 3 mice/group). *P < 0.05 compared to cPLA2α+/+ saline control; ϕP < 0.05 compared to cPLA2α+/+ saline control, #P < 0.05
compared to cPLA2α−/− saline control; **P < 0.05 compared to cPLA2α+/+ with CA. e Representative images of H & E stained lung sections from
saline controls and from C. albicans-infected cPLA2α WT or cPLA2α KO mice are shown. Scale bar = 100 μm
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+/+ and cPLA2α
−/− mice at 12 and 24 h
after instillation of C. albicans or saline by using a cyto-
kine/chemokine PCR array (Additional file 2). C. albicans
infection stimulated an increase in expression of several
pro-inflammatory cytokines (Il1α, Il1β, Tnfα, Il6), and the
immune mediators Csf2 and Ccl20, in lungs of cPLA2α
+/+
and cPLA2α
−/− mice. The level of these cytokines was sig-
nificantly higher in cPLA2α
−/− compared to cPLA2α
+/+mice
particularly 12 h after C. albicans challenge. The chemo-
kines Ccl2, Ccl7 and Cxcl1 were also expressed at higher
levels in cPLA2α
−/− compared to cPLA2α
+/+mice 12 h after
infection, but at 24 h they decreased to a greater extent in
cPLA2α
−/− than cPLA2α
+/+mice. Cxcl10 and Ccl12 in-
creased during C. albicans infection to the same extent in
cPLA2α
+/+ and cPLA2α
−/− mice at 12 h but were signifi-
cantly lower in cPLA2α
−/− than cPLA2α
+/+mice at 24 h.The results evaluating gene expression in the total lung
suggested that cPLA2α activation suppresses the expres-
sion of several pro-inflammatory cytokines but also influ-
ences the duration of gene expression particularly for
certain chemokines (Ccl2, Ccl7, Ccl12, Cxcl1, Cxcl10).
Since C. albicans first encounters cells lining the air-
ways and in the alveoli, cytokines and chemokines were
measured in BALF from cPLA2α
+/+ and cPLA2α
−/− mice
collected 6–24 h after C. albicans infection (Fig. 5). The
pro-inflammatory cytokines IL1α (Fig. 5a), IL1β (Fig. 5b),
TNFα (Fig. 5c) and IL6 (Fig. 5d) were significantly higher
in BALF of cPLA2α
−/− compared to cPLA2α
+/+ mice at
all time points but the time of peak production differed.
IL1α production was transient and peaked at 12 h in
cPLA2α
−/− mice reaching levels that were 8-fold higher
than in cPLA2α
+/+ mice (Fig. 5a). TNFα continued to
Fig. 5 Pro-inflammatory cytokines and chemokines are higher in BALF from cPLA2α−/− than cPLA2α+/+ mice during C. albicans infection. cPLA2α−/−
(KO) and cPLA2α
+/+ (WT) mice were challenged with saline or 106 C. albicans (CA) for 6, 12 and 24 h. The levels of (a) IL1α, (b) IL1β, (c) TNFα, (d) IL6,
(e) CSF2, (f) CCL20, (g) CXCL1 and (h) CSF3 were determined by ELISA (n = 6–10 mice/group in 3–5 experiments). *P < 0.05 compared to cPLA2α+/+
saline control; #P < 0.05 compared to cPLA2α−/− saline control; **P < 0.05 compared to cPLA2α+/+ with CA
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−/− mice for 24 h (Fig. 5c). IL6 was
10-fold higher in cPLA2α
−/− compared to cPLA2α
+/+
mice at 6 and 12 h after infection then decreased by
24 h (Fig. 5d). There was early production of IL1β in
cPLA2α
−/− mice that continued to increase up to 24 h
after C. albicans infection (Fig. 5b). CSF2 (Fig. 5e) and
CCL20 (Fig. 5f ) were significantly higher in cPLA2α
−/−
than cPLA2α
+/+mice at 12 and 24 h after infection. The
neutrophilic chemokine CXCL1 was higher in BALF of
cPLA2α
−/− than cPLA2α
+/+ mice particularly 24 h after
C. albicans infection (Fig. 5g). Although levels of Csf3
mRNA were similar in lungs of C. albicans infected
cPLA2α
−/− and cPLA2α
+/+mice, analysis of BALF showed
that CSF3 was higher in cPLA2α
−/− than cPLA2α
+/+ mice at24 h (Fig. 5h). The results demonstrate that cPLA2α
−/−mice
have higher levels of pro-inflammatory cytokines and che-
mokines consistent with increased neutrophil recruitment.
Levels of eicosanoids in BALF from cPLA2α
+/+ and
cPLA2α
−/− mice during C. albicans infection
cPLA2α releases arachidonic acid for production of eicosa-
noids, which play diverse roles in regulating inflammation
and innate immunity. Eicosanoids were analyzed by mass
spectrometry in BALF collected 24 h after C. albicans in-
fection from cPLA2α
+/+ and cPLA2α
−/− mice (Fig. 6).
Since cyclooxygenase metabolites and oxidation products
can be generated during tissue processing from available
free arachidonic acid, the cyclooxygenase inhibitor
Fig. 6 Eicosanoids are lower in BALF from cPLA2α−/− than cPLA2α+/+ mice during C. albicans infection. Levels of (a) cysteinyl leukotrienes, leukotriene
C4 (LTC4), leukotriene D4 (LTD4) and leukotriene E4 (LTE4) and (b) cyclooxygenase metabolites thromboxane B2 (TXB2), prostaglandin E2 (PGE2),
prostaglandin D2 (PGD2) and 6-keto prostaglandin F1α (6-keto PGF1α) were determined by mass spectrometry in BALF from cPLA2α
−/− (KO) and
cPLA2α+/+ (WT) mice instilled with saline or 106 C. albicans (CA) for 24 h. Results are the mean ± SEM (n = 6 mice/group). Statistical differences were
determined by the Mann Whitney protocol. *P < 0.05 compared to WT saline control; ϕP < 0.05 compared to WT saline control, #P < 0.05 compared to
KO saline control; **P < 0.05 compared to WT with CA
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were added to the lavage solution before administration.
By including D8-arachidonic acid in the lavage solution
along with indomethacin, preliminary experiments
showed that cyclooxygenase products were not gener-
ated during the lavage procedure since D8 metabolites
were not found. In addition we found that it was neces-
sary to include butylated hydroxytoluene during lavage to
prevent the formation of isoprostanes. As shown in Fig. 6,
C. albicans stimulated an increase in cysteinyl leukotriene
production in cPLA2α
+/+ mice with the stable metabolite
leukotriene E4 being the most abundant followed by
leukotriene C4 and leukotriene D4 (Fig. 6a). Cysteinyl
leukotrienes were at very low or undetectable levels in sa-
line controls and in BALF from C. albicans infected
cPLA2α
−/− mice indicating that cPLA2α initiates their pro-
duction. There was no significant production of leukotri-
ene B4 in saline controls or in response to C. albicans
infection in either cPLA2α
+/+ or cPLA2α
−/− mice. The
cyclooxygenase metabolites thromboxane B2 (the stable
metabolite of thromboxane A2), prostaglandin E2 and
prostaglandin D2 were detected at the highest levels in
BALF of C. albicans infected cPLA2α
+/+ mice (Fig. 6b).
Thromboxane B2 and Prostaglandin E2 were significantly
lower in C. albicans-infected cPLA2α
−/− than cPLA2α
+/+
mice. Although prostaglandin D2 levels were lower in C.albicans-infected cPLA2α
−/− mice than cPLA2α
+/+ mice
this did not reach statistical significance. The stable me-
tabolite of prostaglandin I2 (6-keto-prostaglandin F1α) was
detected in BALF at relatively high endogenous levels but
was not increased by C. albicans and not significantly
different in cPLA2α
+/+ and cPLA2α
−/− mice (Fig. 6b).
Therefore the higher levels of cysteinyl leukotrienes,
thromboxane A2 or prostaglandin E2 in cPLA2α
+/+ than
cPLA2α
−/− mice may be important for protecting the lung
against C. albicans infection.




Neutrophils and alveolar macrophages play an important
role in host defense against C. albicans, however, despite
the increase in neutrophil influx in cPLA2α
−/− mice the
fungus was not completely cleared from these mice.
Therefore the ability of these cells to recognize and kill C.
albicans was determined. Alveolar macrophages and neu-
trophils were isolated from uninfected cPLA2α
+/+ and
cPLA2α
−/− mice, and their ability to bind and internalize
GFP-C. albicans (recognition assay) and to kill the fungus
was examined in vitro. The binding/internalization of
GFP-C. albicans (unopsonized and opsonized) by
cPLA2α
+/+ and cPLA2α
−/− alveolar macrophages was
similar but killing of GFP-C. albicans was ~25–30 %
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expressed similar levels of the lectin receptors dectin-1
(Clec7a) and dectin-2 (Clec4n). Neutrophils from
cPLA2α
−/− mice exhibited ~20–30 % less recognition and
killing of GFP-C. albicans than cPLA2α
+/+ neutrophils
(Fig. 7b). Neutrophils from cPLA2α
+/+ and cPLA2α
−/−
mice expressed similar levels of dectin-1 but the levels of
dectin-2 (Clec4n) were significantly higher in neutrophils
from cPLA2α
−/− compared to cPLA2α
+/+mice, although
dectin-2 (Clec4n) expression was 10-fold lower thanFig. 7 Recognition and killing of C. albicans by alveolar macrophages and
alveolar macrophages and (b) neutrophils from untreated cPLA2α+/+ (WT) a
was compared. Levels of clec7a (dectin-1) and clec4n (dectin-2) expression we
by lavage from WT and KO mice 6 h after challenge with GFP-C. albicans and
by microscopy. Results are mean ± SEM (n = 3–4). *p < 0.05 compared to cellsdectin-1 (Clec7a) in neutrophils. We also evaluated the
number of GFP-C. albicans that were engulfed by alveolar
macrophages in vivo, which were isolated by lavage from
cPLA2α
+/+ and cPLA2α
−/− mice 6 h after challenge with
GFP-C. albicans. Alveolar macrophages from cPLA2α
−/−
mice had significantly lower numbers of internalized GFP-
C. albicans than macrophages from cPLA2α
+/+ mice
(Fig. 7b). The results suggest that the higher levels of C.
albicans in cPLA2α
−/− mice may in part be due to a re-
duced capacity of alveolar macrophages and neutrophils
to kill C. albicans.neutrophils from cPLA2α
−/− and cPLA2α
+/+ mice. The ability of (a)
nd cPLA2α−/− (KO) mice to recognize and kill GFP-C. albicans in vitro
re determined by real-time PCR. (c) Alveolar macrophages were isolated
the % macrophages containing internalized GFP-C. albicans determined
from WT mice
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cPLA2α is a highly conserved enzyme that is widely
expressed throughout all tissues in mice and humans,
and is rapidly activated by diverse agonists through com-
mon signaling pathways [1]. It is the only mammalian
PLA2 that preferentially releases sn-2 arachidonic acid
from phospholipids and its role in initiating the pro-
duction of eicosanoids is well documented [40, 41].
Identification of humans with cPLA2α deficiency has
confirmed that it mediates eicosanoid production and
functions in homeostatic processes important for hu-
man health [42–45]. cPLA2α has been implicated in
regulating both normal physiological processes and dis-
ease pathogenesis in many organ systems from studies
using cPLA2α
−/− mice, however, the specific mecha-
nisms involved in many cases have not been elucidated
[1, 46, 47]. In models of lung disease, cPLA2α
−/− mice
are protected from pulmonary fibrosis, acute lung in-
jury and allergic responses [48–50]. Since lung fibrosis
and allergic lung responses are exacerbated in COX-1
−/− and COX-2−/− mice but reduced in 5-LO−/− mice,
the results suggest that in certain pro-inflammatory
disease states cPLA2α contributes to disease through a
dominant role for pro-inflammatory leukotrienes [51–54].
By comparing cPLA2α
+/+ and cPLA2α
−/− mice in this
study, we are probing the primary mechanism for eicosa-
noid production in vivo in response to exposure of the
lung to the opportunistic pathogen C. albicans. This
model reflects the collective influence of lipid mediators
resulting from cPLA2α activation in regulating innate im-
mune responses. Immune competent mice are resistant to
infection from intratracheal instillation of C. albicans,
which is rapidly cleared from the lungs with minimal
health effects due to contributions from both alveolar
macrophages and neutrophils in host defense [35]. Our re-
sults suggest that cPLA2α contributes to innate immune
defense mechanisms in the lung to control C. albicans
infection and dampen inflammation.
cPLA2α
−/− mice do not clear C. albicans from the lung
as efficiently as cPLA2α
+/+ mice and exhibit greater signs
of inflammation including excessive weight loss, in-
creased production of pro-inflammatory cytokines and
increased neutrophil recruitment to the lung. Pro-
inflammatory cytokines (TNFα, IL1α, IL1β) are higher in
cPLA2α
−/− than cPLA2α
+/+ mice 6–24 h after C. albicans
infection. In mouse models of bacterial pneumonia these
cytokines are produced by alveolar macrophages from
initial interaction with pathogens and signal to epithelial
cells and neutrophils to mount responses to infection
[55–57]. Alveolar macrophages, isolated 6 h after intra-
tracheal instillation, contain engulfed GFP-C. albicans
indicating that the fungi reach the alveoli shortly after
instillation. Pro-inflammatory cytokines have been shown
to induce the production of neutrophilic chemokines suchCXCL1, which is higher in cPLA2α
−/− mice and correlates
with the elevated neutrophil influx [56, 58]. C. albicans in-
fection in cPLA2α
+/+ mice leads to a small but significant
increase in production of TNFα, IL1α and IL1β, and
induces neutrophil influx, although at lower levels than in
cPLA2α
−/− mice. It is likely that these innate immune re-
sponses in cPLA2α
+/+ mice are important for host defense
resulting in clearance of C. albicans from the lung. It has
been shown that TNFα, IL1α and IL1β are important for
host defense against invasive C. albicans infection in mice
[59, 60]. However, the exaggerated responses to C. albi-
cans infection in cPLA2α
−/− mice point to an important
role for cPLA2α in regulating the balance of cytokines
produced for effective microbial clearance without excess
inflammation that may cause tissue injury and dissemin-
ation of C. albicans from the lung. This may in part be
due to higher levels of PGE2 in cPLA2α
+/+ mice since
prostaglandins suppress the production of TNFα, IL1α
and IL1β [15, 61–63]. PGE2 is also important in maintain-
ing endothelial barrier function, promoting wound healing
and inhibiting neutrophil migration [64]. PGI2 also has
anti-inflammatory properties [3]. Our results show rela-
tively high levels of endogenous PGI2 in BALF suggesting
constitutive production perhaps by vascular endothelial
cells and smooth muscle cells reflecting its important role
in maintenance of the vasculature [65]. PGI2 levels were
similar in BALF from cPLA2α
+/+ and cPLA2α
−/− mice, and
not increased by C. albicans infection, suggesting another
PLA2 is involved in its production and that it is not in-
volved in the phenotypic differences observed during C.
albicans infection.
Of the cytokines measured in BALF, IL6 showed the
greatest increase in cPLA2α
−/− mice early after C. albi-
cans instillation reaching levels 10-fold higher than in
cPLA2α
+/+ mice. IL6 is an indicator of disease severity,
reflecting the more pronounced effect of C. albicans on
the health of cPLA2α
−/− compared to cPLA2α
+/+ mice,
which show only a small increase in IL6 production [66].
IL6 is considered a pleiotropic cytokine made by im-
mune and stromal cells in response to diverse ago-
nists that has a homeostatic function and regulates
immunity [67]. IL6 regulates the recruitment of leu-
kocytes during infection and may contribute to the
higher neutrophil influx in cPLA2α
−/− mice [67, 68].
Although IL6 can be induced by prostaglandins, its
higher level in cPLA2α
−/− mice suggests that it is dir-
ectly made by cells in response to C. albicans perhaps
through the early production of TNFα, IL1α, and
IL1β [66, 69, 70]. In contrast to the results of this
study, cPLA2α
−/− mice are protected during Pseudo-
monas aeruginosa lung infection that correlates with
decreased IL6 production [71]. Therefore, cPLA2α can
exacerbate infection or have a protective role in the
lung depending on the type of pathogen.
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ing infection by promoting trafficking of neutrophils, T
lymphocytes, dendritic cells and vascular permeability
[2, 7]. Mice deficient in leukotriene production are
more susceptible to bacterial (Klebsiella pneumonia, Myco-
bacterium tuberculosis) and fungal (Histoplasmosis) lung
infection showing impaired microbial clearance and sur-
vival [72–74]. However there are differences in the
responses of leukotriene-deficient mice to bacterial and
fungal infection. Following bacterial challenge, 5-LO−/−
mice have reduced neutrophil influx in the lung [72]. How-
ever, Histoplama capsulatum lung infection in 5-LO−/−
mice results in increased neutrophil recruitment and
greater production of pro-inflammatory cytokines than in
wild type mice, as we observed in C. albicans-infected
cPLA2α
−/− mice. Leukotrienes regulate innate immune
responses in part by enhancing alveolar macrophage
phagocytosis and microbial killing [72, 74].
Our results demonstrate that alveolar macrophages and
neutrophils from uninfected cPLA2α
−/− mice have a re-
duced capacity to kill C. albicans than cells from
cPLA2α
+/+ mice. We previously reported that C. albicans
poorly activates cPLA2α in alveolar macrophages from
cPLA2α
+/+ mice and induces very little eicosanoid produc-
tion, although it is enhanced by priming with GM-CSF
due to increased expression of dectin-1 [12]. Therefore it
is not likely that this inherent difference in the killing cap-
acity of alveolar macrophages from uninfected cPLA2α
+/+
and cPLA2α
−/− mice is due to production of endogenous
eicosanoids during the killing assay in vitro. The basis for
this inherent difference in C. albicans killing is not
known but the lack of eicosanoids during development
of cPLA2α
−/− mice may affect gene expression that in-
fluences killing of C. albicans. The results also showed
that alveolar macrophages isolated from cPLA2α
−/−
mice 6 h after instillation of GFP-C. albicans have
fewer engulfed GFP-C. albicans than macrophages from
cPLA2α
+/+ mice. It is likely that cells are primed by cy-
tokines in vivo to enhance production of eicosanoids
and regulate killing of C. albicans.
A role for the epithelium during C. albicans lung infec-
tion is suggested by results showing that cPLA2α
−/− mice
have higher levels of CCL20 and CSF2 than cPLA2α
+/+
mice. During lung infection CCL20 and CSF2 (GM-CSF)
are derived from lung epithelium and contribute to re-
cruitment of dendritic cells and neutrophils [55, 58, 75].
The lung epithelium may also contribute to production of
pro-inflammatory cytokines since C. albicans stimulates
oral and vaginal epithelial cells to produce chemokines
and cytokines including IL1α, IL1β and TNFα [76, 77]. Al-
though this has not been investigated in lung epithelial
cells, there may be a local immune response at the lung
mucosa for combating C. albicans in cPLA2α
+/+ mice.
It is interesting that C. albicans disseminates to thekidney in cPLA2α
−/− mice suggesting there is damage
to the epithelial/endothelial barrier possibly due to the
increased inflammation. Since alveolar epithelium dam-
age can be sensed by alveolar macrophages this may
lead to heightened pro-inflammatory responses as we
observed in cPLA2α
−/− mice [78]. The results suggest
that cPLA2α activation is an important mechanism for
regulating the function of immune and stromal cells in
the lung to protect from C. albicans infection.
Conclusions
This study demonstrates that cPLA2α plays a role in
protecting the lung from C. albicans infection. Since
production of lipid mediators occurs rapidly in response
microbial infection we focused on how this pathway reg-
ulates the early innate immune responses to C. albicans
in the lung in an attempt to assess the more immediate
effects of this pathway. The results suggest that cPLA2α
contributes to lung homeostasis and the immunosup-
pressive environment in the lung. There may be tonic
pattern receptor signaling resulting in cPLA2α activation
and lipid mediator production in the lung by low-level
colonization or exposure to commensal organisms such
as C. albicans from the oral cavity. This promotes clear-
ance of the relatively avirulent commensal fungus that
limits infection and inflammation preventing more
pathogenic effects. It is likely that the balance of prod-
ucts from both cyclooxygenase and lipoxygenase path-
ways is important in immune surveillance in the lung
contributing to mucosal integrity and the function of
phagocytes for efficient clearance of infectious agents
and regulating the extent of inflammation.
Additional files
Additional file 1: Figure S1. Flow cytometry gating strategy for cell
identification in lung digests from cPLA2α+/+ (WT) and cPLA2α−/− (KO)
mice challenged with C. albicans for 24 h. Cells were isolated from
enzymatically digested mouse lungs, and after exclusion of doublets and
debris, immune cells were identified by CD45 staining. A sequential
gating strategy was used to identify populations expressing specific
markers: a alveolar macrophages (AM) (CD45+ CD24− CD11b− SiglecF+),
(b) tissue macrophages (TM) (CD45+ CD24− CD11b+), (c) neutrophils
(PMN) (CD45+ CD11b+ Ly6G+) and (d) CD11b+ dendritic cells (CD11b+
DCs) (CD45+ MHCII+ CD11c+ CD11b+). (TIF 954 kb)
Additional file 2: Figure S2. Expression of cytokines and chemokines
in lung tissue from cPLA2α+/+ and cPLA2α−/− mice during C. albicans
infection. Real-time PCR was carried out using the Mouse Cytokines &
Chemokines RT2 Profiler PCR Array to compare expression in lungs of
cPLA2α−/− (KO) and cPLA2α+/+ (WT) mice challenged with saline or 106 C.
albicans (CA) for 12 and 24 h (n = 6-10 mice/group in 3–5 experiments).
*P < 0.05 compared to WT saline control; ϕP < 0.05 compared to WT saline
control, #P < 0.05 compared to KO saline control; **P < 0.05 compared to
WT with CA. (TIF 859 kb)
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